Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Depression in Parkinson's disease: symptom improvement and residual symptoms after acute pharmacologic management.

Dobkin RD, Menza M, Bienfait KL, Gara M, Marin H, Mark MH, Dicke A, Friedman J.

Am J Geriatr Psychiatry. 2011 Mar;19(3):222-9. doi: 10.1097/JGP.0b013e3181e448f7.

2.

Treatment of bereavement-related depression and traumatic grief.

Hensley PL.

J Affect Disord. 2006 May;92(1):117-24. Epub 2006 Feb 3. Review.

PMID:
16458978
3.

Social inequalities in response to antidepressant treatment in older adults.

Cohen A, Houck PR, Szanto K, Dew MA, Gilman SE, Reynolds CF 3rd.

Arch Gen Psychiatry. 2006 Jan;63(1):50-6.

PMID:
16389196
4.

Trajectories of treatment response in late-life depression: psychosocial and clinical correlates.

Gildengers AG, Houck PR, Mulsant BH, Dew MA, Aizenstein HJ, Jones BL, Greenhouse J, Pollock BG, Reynolds CF 3rd.

J Clin Psychopharmacol. 2005 Aug;25(4 Suppl 1):S8-13.

PMID:
16027561
5.

Executive functioning, illness course, and relapse/recurrence in continuation and maintenance treatment of late-life depression: is there a relationship?

Butters MA, Bhalla RK, Mulsant BH, Mazumdar S, Houck PR, Begley AE, Dew MA, Pollock BG, Nebes RD, Becker JT, Reynolds CF 3rd.

Am J Geriatr Psychiatry. 2004 Jul-Aug;12(4):387-94.

PMID:
15249276
6.

Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine.

Nebes RD, Pollock BG, Houck PR, Butters MA, Mulsant BH, Zmuda MD, Reynolds CF 3rd.

J Psychiatr Res. 2003 Mar-Apr;37(2):99-108.

PMID:
12842163
7.

Effect of nortriptyline and paroxetine on CYP2D6 activity in depressed elderly patients.

Solai LK, Pollock BG, Mulsant BH, Frye RF, Miller MD, Sweet RA, Kirshner M, Sorisio D, Begley A, Reynolds CF 3rd.

J Clin Psychopharmacol. 2002 Oct;22(5):481-6.

PMID:
12352271
8.

Course and rate of antidepressant response in the very old.

Gildengers AG, Houck PR, Mulsant BH, Pollock BG, Mazumdar S, Miller MD, Dew MA, Frank E, Kupfer DJ, Reynolds CF 3rd.

J Affect Disord. 2002 May;69(1-3):177-84.

PMID:
12103464
9.

Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults.

Fabian TJ, Dew MA, Pollock BG, Reynolds CF 3rd, Mulsant BH, Butters MA, Zmuda MD, Linares AM, Trottini M, Kroboth PD.

Biol Psychiatry. 2001 Nov 15;50(10):767-74.

PMID:
11720695
10.

Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly.

Bump GM, Mulsant BH, Pollock BG, Mazumdar S, Begley AE, Dew MA, Reynolds CF 3rd.

Depress Anxiety. 2001;13(1):38-44.

PMID:
11233459
11.

Depression in Parkinson's Disease.

Richard IH.

Curr Treat Options Neurol. 2000 May;2(3):263-274.

PMID:
11096753
12.

A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-week outcome.

Mulsant BH, Pollock BG, Nebes RD, Miller MD, Little JT, Stack J, Houck PR, Bensasi S, Mazumdar S, Reynolds CF 3rd.

J Clin Psychiatry. 1999;60 Suppl 20:16-20.

13.

High relapse rate after discontinuation of adjunctive medication for elderly patients with recurrent major depression.

Reynolds CF 3rd, Frank E, Perel JM, Mazumdar S, Dew MA, Begley A, Houck PR, Hall M, Mulsant B, Shear MK, Miller MD, Cornes C, Kupfer DJ.

Am J Psychiatry. 1996 Nov;153(11):1418-22.

PMID:
8890674
14.

Recent pharmacologic advances in antidepressant therapy for the elderly.

Preskorn SH.

Am J Med. 1993 May 24;94(5A):2S-12S. Review.

PMID:
8503477

Supplemental Content

Loading ...
Support Center